As a pharma employee, you likely have an employee stock purchase plan (ESPP) as part of your compensation package. What you may not know is that your ESPP is one of the most valuable benefits available to you.
Having worked with hundreds of pharma professionals over the years, I’ve seen firsthand how a well-managed ESPP strategy can enhance the broader financial picture.
Understanding how these plans work is key to unlocking that value, generating some extra income, and establishing sustainable saving and investing habits that will serve you well into the future.
ESPPs Explained: What They Are, How They Work
An employee stock purchase plan allows employees to purchase stock, usually at a discount of up to 15% off the market price.
You must first enroll in the program to activate the benefit. Then, you’ll choose an amount to be deducted from each paycheck, and stock will be purchased on your behalf with that money on a set schedule (the offering period), typically spanning six months to two years.
So, the deductions accumulate over time, and stock is purchased at the end of the offering period.
Once the stock is purchased, it’s yours to hold, sell, or manage as you see fit.
Why ESPPs are so valuable for pharma employees
The reason ESPPs are particularly relevant for pharma employees is because of stock volatility. And while pharma stock values are never predictable, the benefit can be hugely rewarding if the company is doing well.
Unlike RSUs or stock options, there is no company contribution and no vesting period. All funds come directly from you, and you own the stock outright. Because of this, you have more immediate upside potential, aligned directly with the company’s growth.
And yes, a high upside potential also means higher risk, but with a disciplined approach and sound advice from a qualified pharma financial advisor, you can make it work in your favor.
Ultimately, the most significant benefit of an ESPP is the fact that you’re purchasing stock at a discount. So, if the stock price remains stable, you stand to gain quite a bit.
Added value: the lookback provision
Some ESPPs also offer a lookback provision. Essentially, this means stock is purchased based on its value at the start of your offering period, which could translate into substantial savings on top of your discount if the stock has appreciated in value.
Qualified vs. Non-qualified Disposition: What This Means for Your Taxes
There are two tax scenarios to consider that can impact your net returns, depending on whether the ESPP plan is qualified or non-qualified.
Under a qualified plan, you are taxed only when shares are sold. Depending on how long you hold the shares, the income could be taxed as ordinary income or capital gains.
If your plan is non-qualified, you pay tax when shares are purchased, but only on the difference between what you paid and the fair market value of the shares. If you have a non-qualified plan, your employer will likely withhold this amount from your pay. There may also be taxes due when you sell.
It’s worth a quick call to see how we can mitigate the tax impact over time, and certainly it’s a good idea to understand what to expect. Together, we can put a strategy together based on your risk tolerance and long-term financial goals.
Understanding Concentration Risk
Concentration risk happens when too much of your investment is tied up in a single company. Imagine if the company faced an unfortunate regulatory decision, a poor clinical trial outcome, or multiple patent cliffs. These are just a few scenarios that could seriously impact your investment.
Consider that you likely have multiple ways you are exposed, through stock options, bonuses, salary, and RSUs, in addition to your ESPP. That’s a lot riding on the company’s success.
I typically advise selling ESPP shares soon after purchase and reinvesting the funds into a more diversified portfolio. Though you might pay more taxes up front, this strategy allows you to reap the discount and minimize risk.
How Much Should You Contribute?
Most contribution schemes are capped at 10% to 15%.
And while it may be tempting to maximize your ESPP contribution, you’ll need to consider your cash flow needs before making any long-term decisions. You want to ensure you can pay your bills and continue to thrive as your investments grow.
Here are a few things to consider:
- Do you have an emergency fund?
- Have you maxed out your tax-advantaged retirement accounts (RRSPs, 401(k)s)?
- What do your other deductions look like? Will there be enough left over to meet your day-to-day financial needs?
Ideally, you’ll want to strike a balance between long-term opportunity and immediate cash flow. Don’t commit to what you can’t afford.
How Your ESPP Should Fit into Your Long-Term Financial Plan
Your ESPP is an amazing benefit, but it delivers more when it’s part of a holistic financial strategy.
Ideally, you’ll want to align decisions about your ESPP with other equity compensation. Timing the sale of your stock is critical to managing your tax liability, and you’ll want to consider reinvesting to minimize concentration risk.
So many things can impact how you approach these decisions. Are you nearing retirement? Planning to change jobs? Expecting a promotion? Everyone’s situation is unique, and things change all the time, so even if you have a sound strategy, it’s important to review it periodically to ensure you’re still on track to meet your goals and minimize the tax burden.
Here are a few common mistakes you’ll want to avoid where ESPPs are concerned:
- Don’t miss out on participating in the ESPP program if it’s available to you.
- Don’t hold too much company stock to avoid overexposure.
- Don’t ignore the tax implications. Good planning is a must!
- Don’t overcontribute; always consider your cash flow.
With the right strategy in place, your ESPP can help you build wealth and reap the benefits of your company’s success.
And if the idea of putting money into your companies stock leaves you with a mix of concern and uncertainty, you’re not alone.
That’s why it’s critical to step back and evaluate your position with objective, research-backed insight.
You can receive a complimentary Morningstar report on your company stock when you schedule a brief intro call with me.
It’s a simple perk: you get a customized snapshot of what investment researchers are saying (ratings, risks, and key fundamentals) so you can be more informed about your shares. Let's see if working with a Financial Advisor with a pharma focus is a good fit for your needs.
If not, no hard feelings; I’ll point you in the right direction. Book your spot and claim your report here:
